The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue

Rebecca C Schugar1, Diana M Shih2, Manya Warrier1

  • 1Department of Cellular and Molecular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA; Center for Microbiome and Human Health, Cleveland Clinic, Cleveland, OH 44195, USA.

Cell Reports
|June 22, 2017
PubMed

Insights

The gut microbe-generated compound trimethylamine N-oxide (TMAO) is linked to obesity and type 2 diabetes. Reducing the TMAO-producing enzyme flavin-containing monooxygenase 3 (FMO3) protected mice against obesity.

Area of Science:

  • Microbiology
  • Metabolic disorders
  • Obesity research

Background:

  • Gut microbiota plays a crucial role in host energy metabolism and is implicated in obesity-associated disorders.
  • Trimethylamine N-oxide (TMAO) is a metabolite produced by gut microbes, and its role in metabolic diseases is under investigation.

Purpose of the Study:

  • To investigate the link between the gut microbiota-initiated TMAO-generating pathway and obesity and energy metabolism.
  • To explore the association of TMAO levels with type 2 diabetes and obesity traits.
  • To determine the role of flavin-containing monooxygenase 3 (FMO3) in obesity and adipose tissue beiging.

Main Methods:

  • Analysis of systemic TMAO levels in human clinical cohorts and the Hybrid Mouse Diversity Panel.
  • Investigating the effect of FMO3 knockdown or genetic deletion on obesity in mice.
  • Examining the regulatory role of FMO3 in white adipose tissue beiging using mouse and human studies.

Main Results:

  • Systemic TMAO levels strongly associated with type 2 diabetes in human cohorts.
  • Circulating TMAO levels correlated with obesity traits across different inbred mouse strains.
  • FMO3 inhibition or deletion conferred protection against obesity in mice.
  • FMO3 was found to negatively regulate the beiging of white adipose tissue.

Conclusions:

  • The TMAO-generating pathway initiated by gut microbiota is linked to obesity and impaired energy metabolism.
  • FMO3 is a key enzyme in TMAO production and plays a significant role in regulating body weight and adipose tissue function.
  • Targeting FMO3 may represent a potential therapeutic strategy for obesity and related metabolic disorders.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.9K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K